Interactive Brokers Advertisement
Home > Boards > US Listed > Biotechs >

Crispr Therapeutics AG (CRSP)

Add CRSP Price Alert      Hide Sticky   Hide Intro
Search This Board: 
Last Post: 5/23/2017 4:14:46 PM - Followers: 10 - Board type: Free - Posts Today: 0

Crispr Therapeutics AG is a Switzerland-based gene-editing company. The Company focuses on the development of transformative gene-based medicines for serious diseases using its Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas9 gene-editing platform. CRISPR/Cas9 can be programmed to cut, edit and correct disease-associated deoxyribonucleic acid (DNA) in a patient’s cell. The location at which the Cas9 molecular scissors cut the DNA to be edited is specified by guide ribonucleic acid (RNA), which is comprised of a crRNA component and a tracrRNA component, either individually or combined together as a single guide RNA. The Company has business operations in London, the United Kingdom, as well as research and development operations in Cambridge, the United States.
Interactive Brokers Advertisement
Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
CRSP News: CRISPR Therapeutics Awarded Grant from Friedreich’s Ataxia Research Alliance to Collaborate with University of Alabama at B... 10/13/2017 08:30:00 AM
CRSP News: CRISPR Therapeutics to Present at Investor Conferences in October 10/04/2017 04:01:00 PM
CRSP News: Current Report Filing (8-k) 10/02/2017 07:36:35 AM
CRSP News: CRISPR Therapeutics Announces Promotion of Samarth Kulkarni, Ph.D. to Chief Executive Officer 10/02/2017 07:30:00 AM
CRSP News: Amended Statement of Beneficial Ownership (sc 13d/a) 09/15/2017 01:53:23 PM
#1   This will be huge, and I've got myself Migs123 05/23/17 04:14:46 PM